Pharmaceutical News

RSS

Settlements between PBMs, States, indicate need for 'stronger medicine' to address problems, Lazarus writes

A $9.5 million settlement with 28 states announced last week by Express Scripts to resolve allegations that the company had "been pocketing money from pharmaceutical companies to steer patients into name-brand drugs" indicates the need for "some stronger medicine" to address problems in the industry, Los Angeles Times columnist David Lazarus writes.

3 Jun 2008

Most U.S. medical schools do not adequately limit gifts, payments from pharmaceutical industry, report finds

Most U.S. medical schools do not adequately limit gifts and payments from pharmaceutical companies to physicians and students, according to a report released on Tuesday by the American Medical Student Association, the New York Times reports.

3 Jun 2008

Boehringer Ingelheim, Gilead to freeze AIDS drug price

AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.

3 Jun 2008

Latest drug scare in China sees six dead

In the last 10 days six people have died in east China's Jiangxi province after being injected with human immunoglobulin at a hospital in the provincial capital Nanchang.

3 Jun 2008

Biopharmaceutical manufacturing capacity to increase 66% in Europe by 2012, sccording to new report

Production capacity for biopharmaceutical manufacturing will expand an average of 46% over the next five years for mammalian production systems, according to a new report by BioPlan Associates.

2 Jun 2008

Arana and Greenovation in anti-cancer co-development deal

Arana Therapeutics Limited and Germany-based greenovation Biotech GmbH have entered into a collaborative agreement to develop next generation anti-cancer antibodies.

2 Jun 2008

CMS launches campaign to enroll more low-income Medicare beneficiaries in prescription drug assistance program

CMS launched a $12 million outreach campaign last month to encourage low-income Medicare beneficiaries to enroll in the prescription drug assistance program, CongressDaily reports.

2 Jun 2008

Appeals court decisions in Vioxx lawsuits indicate 'sanity still exists' in legal system, editorial states

State appeals courts in New Jersey and Texas last week "delivered a one-two punch to the liability suits against Merck for its Vioxx painkiller," an indication that "some sanity still exists in the tort system -- at least at the appellate level," according to a Wall Street Journal editorial.

2 Jun 2008

Journal of Pharmaceutical Innovation publishes groundbreaking scientific papers

The first scientific papers outlining the progress made on the Product Quality Lifecycle Implementation (PQLI) initiative are being published in the June 2008 issue of the Journal of Pharmaceutical Innovation (JPI).

2 Jun 2008

New breast cancer drug combo shrinks aggressive tumours

An international trial of a new breast cancer drug has shown the drug is able to shrink tumours caused by one of the most aggressive forms of the disease.

2 Jun 2008

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

Peregrine Pharmaceuticals, Inc. has announced that results from a Phase I clinical trial of its lead anti-phosphatidylserine (anti-PS) antibody bavituximab in combination with chemotherapy in patients with advanced cancer were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.

2 Jun 2008

Mylan acquires generics businesses of Merck KGaA

Mylan Inc. today announced that it has acquired Merck KGaA's Central & Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic.

2 Jun 2008

Oncolytics Biotech announces results for intravenous Reolysin in patients with sarcomas metastatic to the lung

Oncolytics Biotech Inc. has announced that interim results of a Phase II study of intravenous Reolysin in patients with sarcomas metastatic to the lung were presented yesterday at the American Society of Clinical Oncology (ASCO) annual meeting.

2 Jun 2008

Medarex announces preliminary data for investigational anti-PD-1 antibody

Medarex, Inc. has announced preliminary data from an ongoing Phase 1 study of MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody.

2 Jun 2008

IDM Pharma presents new data on IDM-2101 in non-small cell lung cancer

IDM Pharma, Inc. today announced follow-up results from the Phase 2 study of IDM-2101 showing that the product candidate was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in HLA-A2 positive patients with non-small cell lung cancer (NSCLC) who were treated with IDM-2101, compared to a parallel external control group of HLA-A2 negative non-treated patients.

2 Jun 2008

Watson receives approval of Omeprazole delayed-release capsules

Watson Pharmaceuticals, Inc. has announced today that it has received final approval from the U.S. Food and Drug Administration ("FDA") of its Abbreviated New Drug Application (ANDA) for Omeprazole Delayed-Release Capsules USP in the 10mg, 20mg and 40mg strengths.

2 Jun 2008

BiPar Sciences presents data for novel DNA repair inhibitor

BiPar Sciences, Inc. today announced the results of first-in-human clinical studies of its lead product, BSI-201, in patients with solid tumors.

2 Jun 2008

Genta announces initial trial results for novel drug for bone disease

Genta Incorporated has announced the release of final results from the Company's Phase 1 clinical trial of G4544, a proprietary small molecule that is intended as a treatment for diseases associated with accelerated bone loss. Results showed that the drug was very well-tolerated, and that blood levels were achieved in a range that is known to be clinically bioactive. The data were featured in a poster session at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on Saturday, May 31, 2008.

2 Jun 2008

Connecticut Attorney General files lawsuit against McKesson over alleged inflation of prescription drug prices

Connecticut Attorney General Richard Blumenthal (D) on Thursday filed a lawsuit in U.S. District Court in Boston over allegations that prescription drug distributor McKesson conspired to inflate the average wholesale prices of hundreds of brand-name medications in violation of federal racketeering and state consumer protection laws, the AP/Hartford Courant reports.

30 May 2008

Appeals courts overturn two verdicts, judgment on award payment in Vioxx lawsuits

State appeals courts in New Jersey and Texas on Thursday reversed two jury verdicts and a judgment on payment of legal fees in lawsuits related to the COX-2 inhibitor Vioxx that would have required Merck to pay about $37 million, Bloomberg/Washington Post reports (Van Voris/Voreacos, Bloomberg/Washington Post, 5/30).

30 May 2008

Pharmaceutical News

Settlements between PBMs, States, indicate need for 'stronger medicine' to address problems, Lazarus writes

Most U.S. medical schools do not adequately limit gifts, payments from pharmaceutical industry, report finds

Boehringer Ingelheim, Gilead to freeze AIDS drug price

Latest drug scare in China sees six dead

Biopharmaceutical manufacturing capacity to increase 66% in Europe by 2012, sccording to new report

Arana and Greenovation in anti-cancer co-development deal

CMS launches campaign to enroll more low-income Medicare beneficiaries in prescription drug assistance program

Appeals court decisions in Vioxx lawsuits indicate 'sanity still exists' in legal system, editorial states

Journal of Pharmaceutical Innovation publishes groundbreaking scientific papers

New breast cancer drug combo shrinks aggressive tumours

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

Mylan acquires generics businesses of Merck KGaA

Oncolytics Biotech announces results for intravenous Reolysin in patients with sarcomas metastatic to the lung

Medarex announces preliminary data for investigational anti-PD-1 antibody

IDM Pharma presents new data on IDM-2101 in non-small cell lung cancer

Watson receives approval of Omeprazole delayed-release capsules

BiPar Sciences presents data for novel DNA repair inhibitor

Genta announces initial trial results for novel drug for bone disease

Connecticut Attorney General files lawsuit against McKesson over alleged inflation of prescription drug prices

Appeals courts overturn two verdicts, judgment on award payment in Vioxx lawsuits

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News